3TV8

pharmacological chaperoning in human alpha-galactosidase

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 117
  • Norm. En. per Res.: -2.9408
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-41.3233	-25.9724	-276.783	-344.0787	117	9	0	10292	3	53	28

Interface residues

• A-B: ARG301A, ARG301B, ARG363A, ARG363B, ARG404A, ARG404B, ARG49A, ARG49B, ASN272A, ASN272B, ASN278A, ASN278B, ASN298A, ASN298B, ASN355A, ASN355B, ASN408A, ASN408B, ASN53A, ASN53B, ASP231A, ASP231B, ASP233A, ASP233B, ASP234A, ASP234B, ASP299A, ASP299B, ASP55B, ASP61B, CYS52A, CYS52B, GLN279A, GLN279B, GLN280A, GLN280B, GLN306A, GLN306B, GLN357A, GLN357B, GLU358A, GLU358B, GLU48A, GLU48B, GLU58A, GLU58B, GLU59A, GLU59B, GLY274A, GLY274B, GLY360A, GLY360B, GLY361A, GLY361B, GLY411A, GLY411B, HIS302A, HIS302B, HIS406A, HIS406B, HIS46A, HIS46B, ILE232A, ILE232B, ILE359A, ILE359B, ILE407A, ILE407B, LEU275A, LEU275B, LYS237A, LYS237B, LYS240A, LYS240B, MET267A, MET267B, MET51A, MET51B, PHE273A, PHE273B, PHE50A, PHE50B, PRO305A, PRO305B, PRO362A, PRO362B, PRO409A, PRO409B, PRO60A, PRO60B, SER235A, SER235B, SER238A, SER238B, SER276A, SER276B, SER297A, SER297B, SER304A, SER304B, SER364A, SER364B, SER62A, SER62B, THR366A, THR366B, THR410A, THR410B, TRP236A, TRP236B, TRP277A, TRP277B, TRP47A, TRP47B, TYR365A, VAL269A, VAL269B